An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer.
Matsukawa A, Litterio G, Cormio A, Miszczyk M, Kardoust Parizi M, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Laukhtina E, Rajwa P, Mori K, Chlosta P, Marchioni M, Schips L, Miki J, Kimura T, Shariat SF, Yanagisawa T.
Matsukawa A, et al. Among authors: mori k.
Cancers (Basel). 2025 Jan 9;17(2):205. doi: 10.3390/cancers17020205.
Cancers (Basel). 2025.
PMID: 39857987
Free article.
Review.